Project Aim

The aim of this project was to establish proof-of-concept for a new type of treatment method using adeno-associated viral vectors (AAV) along with a gene editing tool called CRISPR-Cas9, designed specifically for Usher Syndrome subtype 1 (Usher 1b and 1f subtypes) Australian patients. This treatment was tested on retinal organoids (mini versions of the retina) grown from cells taken from these patients to assess for treatment efficacy.

Project Results and Impact

  • The process of growing retinal organoids in the lab was improved ensuring the optimal production of photoreceptor cells, and other types of retinal cells.
  • Safe viral vectors known as AAVs were developed to repair specific sections of genes associated with Usher Syndrome. The most effective guide RNAs, which act like messengers in the cells, were identified to assist in the gene editing process, genetic scissors, enabling efficiencies in treating retinal organoids in the lab.
  • The research demonstrated strong cutting efficiency in the treated retinal organoids, indicating the potential effectiveness of the gene editing approach. The use of small fat particles called lipid nanoparticles (LNPs) was successfully tested and therefore may be a new way to deliver gene therapy to the retina without keeping the gene-editing tools working for too long which may increase the risk to disruptions in the DNA.
  • Specific biomarkers were identified, and tests were created to check whether the gene therapy was working. These tests help us understand if the gene therapy is effective in treating the disease.

Chief investigator:
Dr Anai Gonzalez-Cordero
Children’s Medical Research Institute, Sydney


Dr Samantha Ginn, Children’s Medical Research Institute, Sydney

Work of PhD student Miss Vivienne Kaiser, Children’s Medical Research Institute, Sydney

Grant awarded:
$55,774 (2023)

1 Year

Research Impact Reports

Using RNA-silencing to tackle neuroinflammation in retinal degeneration

Project Aim  The aim of this project is to develop...

Improving real-world mobility and assessing long-term safety outcomes with a retinal prosthesis (“Bionic Eye”)

Project Aim This project aimed to measure visual outcomes of...

RNA base editing strategies as potential therapeutic of inherited retinal dystrophies

Project Aim This study aimed to use a new genetic...

Neuroprotective effect of SAHA in Retinitis Pigmentosa. Do time and frequency matter?

Project Aim Retinitis Pigmentosa (RP) is a genetic, blinding retinal...